Swaminathan S, Leung N, Lager DJ, Melton LJ, Bergstralh EJ, Rohlinger A, Fervenza FC: Changing incidence of glomerular disease in Olmstead County, Minnesota: A 30-year renal biopsy study. Clin J Am Soc Nephrol. 2006, 1: 483-487. 10.2215/CJN.00710805.
Article
PubMed
Google Scholar
Abrantes MM, Cardoso LS, Lima EM, Silva JM, Diniz JS, Bambirra EA, Oliveira EA: Clinical course of 110 children and adolescents with primary focal segmental glomerulosclerosis. Pediatr Nephrol. 2006, 21: 482-9. 10.1007/s00467-006-0019-4.
Article
PubMed
Google Scholar
Rydel JJ, Korbet SM, Borok RZ, Schwartz MM: Focal segmental glomerular sclerosis in adults: presentation, course, and response to treatment. Am J Kid Dis. 1995, 25: 534-542. 10.1016/0272-6386(95)90120-5.
Article
CAS
PubMed
Google Scholar
Bakir AA, Share DS, Levy PS, Arruda JA, Dunea G: Focal segmental glomerulosclerosis in adult African Americans. Clin Nephrol. 1996, 46: 306-311.
CAS
PubMed
Google Scholar
Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL: A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int. 1999, 56: 2220-6. 10.1046/j.1523-1755.1999.00778.x.
Article
CAS
PubMed
Google Scholar
Alexopoulos E, Stangou M, Papagianni A, Pantzaki A, Papadimitriou M: Factors influencing the course and response to treatment in primary focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2000, 15: 1348-56. 10.1093/ndt/15.9.1348.
Article
CAS
PubMed
Google Scholar
Chum MJ, Korbet SM, Schwartz MM, Lewis EJ: Focal segmental glomerular sclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants. J Am Soc Nephrol. 2004, 15: 2169-77. 10.1097/01.ASN.0000135051.62500.97.
Article
Google Scholar
Moranne O, Watier L, Rossert J, Stengel B: GN-Progress Study Group. Primary glomerulonephritis: an update on renal survival and determinants of progression. QJM. 2008, 101: 215-24. 10.1093/qjmed/hcm142.
Article
CAS
PubMed
Google Scholar
Barnett AH: Redefining the role of thiazolidinediones in the management of type 2 diabetes. Vasc Health Risk Manag. 2009, 5: 141-151.
Article
CAS
PubMed
PubMed Central
Google Scholar
Esposito E, Cuzzocrea S: TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma. Curr Med Chem. 2009, 16: 3152-3167. 10.2174/092986709788803024.
Article
CAS
PubMed
Google Scholar
Joy MS, Gipson DS, Dike M, Powell L, Thompson A, Vento S, Eddy E, Fogo AB, Kopp JB, Cattran D, Trachtman H: Phase I trial of rosiglitazone in FSGS: I. Report of the FONT study group. Clin J Am Soc Nephrol. 2009, 4: 39-47. 10.2215/CJN.02310508.
Article
CAS
PubMed
PubMed Central
Google Scholar
Joy MS, Gipson DS, Powell L, MacHardy J, Jennette JC, Vento S, Pan C, Savin V, Eddy E, Fogo AB, Kopp JB, Cattran D, Trachtman H: Phase I trial of adalimumab in focal segmental glomerulosclerosis (FSGS): II. Report of the FONT (Novel therapies for resistant FSGS) study group. Am J Kidney Dis. 2010, 55: 50-60. 10.1053/j.ajkd.2009.08.019.
Article
CAS
PubMed
Google Scholar
Woroniecki RP, Kopp JB: Genetics of focal segmental glomerulosclerosis. Pediatr Nephrol. 2007, 22: 638-644. 10.1007/s00467-007-0445-y.
Article
PubMed
PubMed Central
Google Scholar
Stevens LA, Greene T, Levey AS: Surrogate end points for clinical trials of kidney disease progression. Clin J Am Soc Nephrol. 2006, 1: 874-884. 10.2215/CJN.00600206.
Article
PubMed
Google Scholar
Proteinuria as a surrogate outcome in chronic kidney disease. Proceedings of NKF-FDA conference, Bethesda, MD. 2008
Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR: Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med. 2008, 359: 1565-1576. 10.1056/NEJMoa0806359.
Article
CAS
PubMed
Google Scholar
Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA: 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008, 359: 1577-89. 10.1056/NEJMoa0806470.
Article
CAS
PubMed
Google Scholar
Chalmers J, Cooper ME: UKPDS and the legacy effect. N Engl J Med. 2008, 359: 1618-1620. 10.1056/NEJMe0807625.
Article
CAS
PubMed
Google Scholar
Schwartz GW, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL: New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009, 20: 629-637. 10.1681/ASN.2008030287.
Article
PubMed
PubMed Central
Google Scholar
Tidman M, Sjostrom P, Jones I: A comparison of GFR estimating formulae based upon s-cystatin C and s-creatinine and a combination of the two. Nephrol Dial Transplant. 2008, 23: 154-160. 10.1093/ndt/gfm661.
Article
CAS
PubMed
Google Scholar
Soares AA, Eyff TF, Campani RB, Ritter L, Camargo JL, Silveiro SP: Glomerular filtration rate measurement and prediction equations. Clin Chem Lab Med. 2009, 47: 1023-1032. 10.1515/CCLM.2009.263.
Article
CAS
PubMed
Google Scholar